混合PET/MRI与PET/CT在妇科恶性肿瘤中的可行性及诊断效能比较:一项前瞻性先导研究
前瞻性纳入25例妇科恶性肿瘤患者,最终分析18例(中位年龄62岁,11例宫颈癌、7例子宫内膜癌),单次注射F-18 FDG后序贯行全身PET/CT和腹部盆腔PET/MRI。PET/MRI与PET/CT均检出全部原发肿瘤和区域淋巴结转移,PET/MRI额外检出宫旁浸润和膀胱侵犯,但PET/CT检出2例腹盆腔外淋巴结而PET/MRI未检出;PET/MRI可行且诊断能力至少与PET/CT相当。
要点
- PET/MRI与PET/CT均检出全部原发宫颈癌和子宫内膜癌及区域淋巴结转移。
- PET/MRI额外显示6例宫旁浸润和1例膀胱侵犯,PET/CT未检出。
- PET/CT显示2例腹盆腔外淋巴结转移而PET/MRI未显示。
核心结论
- PET/MRI可行,对原发宫颈癌和子宫内膜癌及区域转移的识别能力至少与PET/CT相当,对宫颈癌初始影像评估可能优于PET/CT。
研究设计与样本
- 前瞻性先导研究,25例妇科恶性肿瘤患者入组,最终分析18例;单次注射F-18 FDG后序贯行全身PET/CT和腹部盆腔PET/MRI,由两名影像科专家独立盲法阅片,参考临床和病理资料。
关键影像表现/征象
- PET/MRI与PET/CT均检出全部原发肿瘤、7/7例区域淋巴结转移和1/1例腹部转移。
- PET/MRI显示6例宫旁浸润和1例膀胱侵犯,PET/CT未检出。
- PET/CT显示2例腹盆腔外淋巴结转移,PET/MRI未显示。
临床应用与阅片要点
- 5例宫颈癌患者基于PET/MRI检出的软组织受侵,临床分期与影像分期不一致。
- 2例宫颈癌患者因PET/MRI结果使处理方案发生改变(临床分期IB1、影像分期IIB)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The purpose of the study was to assess the feasibility and diagnostic performance of FDG-PET/MR imaging compared to PET/CT for staging of patients with a gynecological malignancy.
METHODS: 25 patients with a gynecological malignancy were prospectively enrolled into this pilot study. Patients underwent sequential full-body PET/CT and PET/MR of the abdomen and pelvis after administration of a single dose of F-18 FDG. PET/MRI and PET/CT images were independently reviewed by two expert radiologists. Readers were blinded to the results of the other imaging procedures. Clinical and pathologic information was abstracted from medical charts.
RESULTS: 18 patients were included in the final analysis with a median age of 62 years (range 31-88). 61% of patients (11/18) had cervical cancer, while the remaining patients had endometrial cancer. PET/MRI as compared to PET/CT detected all primary tumors, 7/7 patients with regional lymph nodes, and 1/1 patient with an abdominal metastasis. Two patients had additional lymph nodes outside of the abdominopelvic cavity detected on PET/CT that were not seen on PET/MRI, whereas 6 patients had parametrial invasion and one patient had invasion of the bladder seen on PET/MRI not detected on PET/CT. Five cervical cancer patients had discordant clinical vs. radiographic staging based on PET/MRI detection of soft tissue involvement. Management changed for two patients who had clinical stage IB1 and radiographic stage IIB cervical cancer.
CONCLUSIONS: PET/MRI is feasible and has at least comparable diagnostic ability to PET/CT for identification of primary cervical and endometrial tumors and regional metastases. PET/MRI may be superior to PET/CT for initial radiographic assessment of cervical cancers.
引用
- Schwartz M, Gavane SC, Bou-Ayache J, et al. Feasibility and diagnostic performance of hybrid PET/MRI compared with PET/CT for gynecological malignancies: a prospective pilot study. Abdom Radiol (NY). 2018. PMID: 29948057. doi:10.1007/s00261-018-1665-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。